Study guide
13.5 Enzyme Kinetics: Michaelis-Menten Model, Lineweaver-Burk Analysis, and Enzyme Inhibition
PRC Chemist Licensure Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Chemistry Law (RA 10657), and Laboratory Safety
1.1 PRC Chemist Licensure Examination: Format, Schedule, Grading, and Passing Standards 1.2 Republic Act 10657 (Chemistry Profession Act) and Professional Ethics 1.3 Chemical Laboratory Safety, GHS Classification, Hazardous Waste Management, and Quality Assurance
2 Chapter 2: Inorganic Chemistry: Atomic Structure, Periodicity, and Chemical Bonding
2.1 Atoms, Ions, Compounds, Inorganic Nomenclature, and Stoichiometry 2.2 Quantum Numbers, Electronic Configurations, and Periodic Trends 2.3 Chemical Bonding Models: Lewis Structures, VSEPR Theory, and Molecular Polarity 2.4 Molecular Orbital Theory and Magnetochemistry of Diatomic Molecules
3 Chapter 3: Inorganic Chemistry: Coordination Compounds and Transition Metals
3.1 Coordination Chemistry: Nomenclature, Formulas, and Isomerism 3.2 Crystal Field Theory, Ligand Field Theory, d-Orbital Splitting, and Reaction Mechanisms 3.3 Electronic Absorption Spectra, Tanabe-Sugano Diagrams, and Magnetic Properties
4 Chapter 4: Inorganic Chemistry: Main Group, Reactivity, Solid State, Nuclear, and Applied Topics
4.1 Systematic Descriptive Chemistry of Main Group Elements (s- and p-Blocks) 4.2 Reactivity of Inorganic Compounds: Acid-Base Concepts, HSAB, and Redox Diagrams 4.3 Solid-State Chemistry: Crystal Systems, Unit Cells, and Band Theory 4.4 Bioinorganic Chemistry: Metalloproteins, Oxygen Carriers, and Metal Ion Toxicity 4.5 Organometallic Chemistry: 18-Electron Rule, Carbonyl Complexes, and Catalysis 4.6 Nuclear Chemistry: Stability, Decay, Transmutation, and Radioanalytical Methods 4.7 Industrial, Environmental, and Atmospheric Inorganic Chemistry and Advanced Materials
5 Chapter 5: Analytical Chemistry: Measurements, Statistics, Classical Wet Analysis, and Chemical Equilibria
5.1 Analytical Measurements: Apparatus, Units, Concentration, Sampling, and Sample Preparation 5.2 Analytical Data Evaluation: Errors, Uncertainty, Statistics, and Calibration 5.3 Gravimetric Analysis and Precipitation Equilibria ($K_{sp}$) 5.4 Neutralization Titrimetry, Polyprotic Systems, Buffers, and Alpha Fractions 5.5 Complexometric (EDTA), Redox, and Precipitation (Argentometric) Titrimetry
6 Chapter 6: Analytical Chemistry: Electroanalytical Methods and Separations
6.1 Potentiometry, Ion-Selective Electrodes, and Voltammetric Techniques 6.2 Analytical Separations: Solvent Extraction, SPE, Ion Exchange, Precipitation, Masking, and Electrodeposition 6.3 Fundamentals of Chromatography: Theoretical Plates, Resolution, and van Deemter Equation 6.4 Gas Chromatography (GC): Columns, Stationary Phases, Detectors, and Applications 6.5 High-Performance Liquid Chromatography (HPLC): Normal vs. Reversed Phase and Method Development
7 Chapter 7: Analytical Chemistry: Spectroscopic, Mass Spectrometric, and Other Instrumental Methods
7.1 Molecular UV-Vis Spectroscopy and Quantitative Beer-Lambert Law 7.2 Infrared (FTIR) and Raman Spectroscopy: Vibrational Modes and Instrumentation 7.3 Atomic Spectroscopy: Atomic Absorption (AAS) and Inductively Coupled Plasma (ICP-OES/MS) 7.4 Mass Spectrometry: Ionization Sources, Mass Analyzers, and Fragmentation Analysis 7.5 Other Instrumental Methods (XRF, Flame Emission, CE, SFC, Thermal Analysis, Electronics) and Method Selection
8 Chapter 8: Physical Chemistry: Gases, Thermodynamics, and Thermochemistry
8.1 Ideal and Real Gases and the Kinetic Molecular Theory 8.2 First Law of Thermodynamics: Heat, Work, Internal Energy, and Enthalpy 8.3 Second and Third Laws of Thermodynamics: Entropy, Carnot Engine, and Absolute Entropies 8.4 Gibbs and Helmholtz Free Energy, Spontaneity, and Fundamental Equations 8.5 Chemical Potential, Partial Molar Quantities, Fugacity, and Activity
9 Chapter 9: Physical Chemistry: Equilibrium, Phase Equilibria, Solutions, and Electrochemistry
9.1 Chemical Equilibrium: Equilibrium Constants, Le Chatelier's Principle, and the van 't Hoff Equation 9.2 Phase Rule, Phase Diagrams of One- and Two-Component Systems, and Clausius-Clapeyron Equation 9.3 Solutions: Raoult's and Henry's Laws, Colligative Properties, and Electrolytes 9.4 Electrochemistry: Galvanic Cells, Standard Potentials, and the Nernst Equation 9.5 Electrolyte Conductance, Ionic Mobility, Transport Numbers, and Concentration Cells
10 Chapter 10: Physical Chemistry: Kinetics, Surface Chemistry, and Quantum Mechanics
10.1 Reaction Rates, Rate Laws, and Integrated Rate Equations 10.2 Temperature Dependence of Rates: Arrhenius Equation, Collision Theory, and Transition State Theory 10.3 Reaction Mechanisms: Steady-State Approximation, Chain Reactions, and Catalysis 10.4 Surface Chemistry, Adsorption Isotherms, Colloids, and Macromolecular Solutions 10.5 Postulates of Quantum Mechanics, Operators, Particle in a Box, and Harmonic Oscillator 10.6 Atomic Spectra, the Hydrogen Atom, Many-Electron Atoms, and Term Symbols
11 Chapter 11: Organic Chemistry: Structure, Stereochemistry, and Hydrocarbons
11.1 Systematic IUPAC Nomenclature and Conformational Analysis of Alkanes and Cycloalkanes 11.2 Stereochemistry: Chirality, Enantiomers, Diastereomers, (R)/(S) Configuration, and Optical Activity 11.3 Alkenes and Alkynes: Addition Reactions, Markovnikov Rule, and Stereospecificity 11.4 Aromaticity: Hückel's Rule, Electrophilic Aromatic Substitution, and Directing Effects
12 Chapter 12: Organic Chemistry: Functional Groups, Mechanisms, Synthesis, and Structure Elucidation
12.1 Nucleophilic Aliphatic Substitution ($S_N1$, $S_N2$) and Elimination ($E_1$, $E_2$) Mechanisms 12.2 Alcohols, Phenols, Ethers, and Epoxides: Structure, Synthesis, and Reactivity 12.3 Carbonyl Compounds I: Aldehydes and Ketones, Nucleophilic Addition, and Oxidation/Reduction 12.4 Carbonyl Compounds II: Carboxylic Acids and Derivatives, Enolate Chemistry, and Condensations 12.5 Amines: Basicity, Synthesis, Reactions, and Arenediazonium Chemistry 12.6 Structure Elucidation: NMR Spectroscopy, Combined Spectral Problems, and Qualitative Organic Tests 12.7 Organic Synthesis Strategy, Protecting Groups, Rearrangements, and Pericyclic Reactions
13 Chapter 13: Biochemistry: Cells, Biomolecules, Enzymes, and Membranes
13.1 Cells, Organelles, Water, and Biological Acid-Base Buffers 13.2 Amino Acids, Peptides, and Hierarchical Protein Structure 13.3 Protein Purification and Biochemical Analysis of Proteins, Carbohydrates, and Lipids 13.4 Enzyme Nomenclature and Classification, Cofactors, Coenzymes, and Vitamin Precursors 13.5 Enzyme Kinetics: Michaelis-Menten Model, Lineweaver-Burk Analysis, and Enzyme Inhibition 13.6 Carbohydrates, Lipids, Biological Membranes, and Membrane Transport
14 Chapter 14: Biochemistry: Metabolism, Bioenergetics, Photosynthesis, and Molecular Genetics
14.1 Carbohydrate Catabolism and Anabolism: Glycolysis, Gluconeogenesis, Glycogen, and Pentose Phosphate Pathway 14.2 Citric Acid Cycle, Mitochondrial Electron Transport, Oxidative Phosphorylation, and $\beta$-Oxidation 14.3 Photosynthesis: Light Reactions, Photophosphorylation, and the Calvin Cycle 14.4 Lipolysis and Lipid Biosynthesis: Fatty Acids, Triacylglycerols, and Cholesterol 14.5 Nitrogen Metabolism: Nitrogen Fixation, Amino Acid Metabolism, and the Urea Cycle 14.6 Nucleic Acids, DNA Replication, Transcription, Translation, and Recombinant DNA Techniques 14.7 Regulation of Gene Expression, Mutation and Mutagens, DNA Repair, Carcinogenesis, and cDNA Cloning
13.5 Enzyme Kinetics: Michaelis-Menten Model, Lineweaver-Burk Analysis, and Enzyme Inhibition
Key Takeaways Explain This Topic AI
Enzymes function as biological catalysts by selectively stabilizing the transition state, thereby reducing the free energy of activation ( Δ G ‡ \Delta G^\ddagger Δ G ‡ ) by factors of 10 6 10^6 1 0 6 to 10 17 10^{17} 1 0 17 without altering reaction equilibrium ( K eq K_{\text{eq}} K eq ) or standard free energy change ( Δ G ∘ \Delta G^\circ Δ G ∘ ).
The catalytic triad of serine proteases (Chymotrypsin: Asp102, His57, Ser195) activates Ser195 into a potent alkoxide nucleophile via general base proton abstraction by His57, while the oxyanion hole stabilizes the high-energy tetrahedral transition states through backbone amide hydrogen bonding.
The Briggs-Haldane steady-state approximation assumes that the concentration of the enzyme-substrate intermediate ([ES]) remains constant during initial velocity measurements, yielding the Michaelis-Menten rate law v 0 = ( V max [ S ] ) / ( K m + [ S ] ) v_0 = (V_{\text{max}}[S]) / (K_m + [S]) v 0 = ( V max [ S ]) / ( K m + [ S ]) , where K m K_m K m represents the substrate concentration at half-maximal velocity.
Catalytic efficiency is measured by the second-order rate constant k cat / K m k_{\text{cat}} / K_m k cat / K m , which has a physical upper limit of 10 8 10^8 1 0 8 to 10 9 M − 1 s − 1 10^9\text{ M}^{-1}\text{s}^{-1} 1 0 9 M − 1 s − 1 governed by the rate of aqueous diffusion ('catalytic perfection').
Reversible inhibitors display distinct Lineweaver-Burk double-reciprocal signatures: competitive inhibitors increase apparent K m K_m K m without altering V max V_{\text{max}} V max (intersect on y-axis), uncompetitive inhibitors decrease both apparent K m K_m K m and V max V_{\text{max}} V max by identical ratios (parallel lines), and non-competitive inhibitors decrease V max V_{\text{max}} V max with unchanged K m K_m K m (intersect on x-axis).
Last updated: October 2026
13.5 Enzyme Kinetics: Michaelis-Menten Model, Lineweaver-Burk Analysis, and Enzyme Inhibition
Quick Answer: Enzymes accelerate biochemical transformations by lowering the activation energy barrier ( Δ G ‡ \Delta G^\ddagger Δ G ‡ ) through preferential binding and stabilization of the transition state ( S ‡ S^\ddagger S ‡ ). They leave the thermodynamic equilibrium constant ( K eq K_{\text{eq}} K eq ) and standard free energy change ( Δ G ∘ \Delta G^\circ Δ G ∘ ) completely unaltered. In chymotrypsin, the catalytic triad (Asp102-His57-Ser195) coordinates nucleophilic attack, with the oxyanion hole stabilizing the negative charge on the tetrahedral intermediates. The Michaelis-Menten equation, v 0 = V max [ S ] K m + [ S ] v_0 = \frac{V_{\text{max}}[S]}{K_m + [S]} v 0 = K m + [ S ] V max [ S ] , derived under the Briggs-Haldane steady-state approximation ( d [ E S ] d t = 0 \frac{d[ES]}{dt} = 0 d t d [ ES ] = 0 ), defines K m K_m K m as the substrate concentration at half-maximal velocity ( v 0 = 1 2 V max v_0 = \frac{1}{2}V_{\text{max}} v 0 = 2 1 V max ). Catalytic efficiency is expressed as k cat / K m k_{\text{cat}}/K_m k cat / K m , with a diffusion-controlled ceiling of 10 8 − 10 9 M − 1 s − 1 10^8 - 10^9\text{ M}^{-1}\text{s}^{-1} 1 0 8 − 1 0 9 M − 1 s − 1 . Double-reciprocal Lineweaver-Burk plots diagnostic for inhibition reveal: competitive inhibition increases apparent K m K_m K m ( V max V_{\text{max}} V max unchanged; lines intersect at y y y -axis), uncompetitive inhibition decreases both V max V_{\text{max}} V max and K m K_m K m equally (parallel lines), and non-competitive inhibition decreases V max V_{\text{max}} V max ( K m K_m K m unchanged; lines intersect at negative x x x -axis).
Principles of Enzymatic Catalysis and Transition State Theory
Enzymes are stereospecific macromolecular catalysts—predominantly proteins, alongside catalytic RNAs (ribozymes)—that accelerate chemical reaction rates by factors of 10 6 10^6 1 0 6 to 10 17 10^{17} 1 0 17 under mild physiological conditions ( 1 atm 1\text{ atm} 1 atm , 37 ∘ C 37^\circ\text{C} 3 7 ∘ C , pH 7.0 − 7.4 \text{pH } 7.0-7.4 pH 7.0 − 7.4 ). Free Energy Profile of Uncatalyzed vs. Enzymatically Catalyzed Reactions:
- Free ^
- Energy| ‡ (Uncatalyzed Transition State, high ΔG‡_uncat)
- G | / \
- | / \ ‡ (Catalyzed Transition State, lower ΔG‡_cat)
- | / \ / \
- | S ----+ \ / \
- | (Substrate) \ ES-+ \ P (Product)
- | \ \-/
- | \-----------/
- +---------------------------------------------> Reaction Coordinate
- |<-------- ΔG° remains unchanged ------->|
- Thermodynamic Invariants
To master licensure enzyme questions, remember these core thermodynamic principles:
Activation Energy: Enzymes lower the Gibbs free energy of activation ( Δ G ‡ \Delta G^\ddagger Δ G ‡ ). According to the transition state equation ( k = k B T h e − Δ G ‡ / R T k = \frac{k_B T}{h} e^{-\Delta G^\ddagger / RT} k = h k B T e − Δ G ‡ / RT ), reducing Δ G ‡ \Delta G^\ddagger Δ G ‡ exponentially accelerates the rate constant ( k k k ).
Equilibrium Invariance: Enzymes do NOT alter the reaction equilibrium constant ( K eq K_{\text{eq}} K eq ) or the net standard free energy change of the reaction ( Δ G ∘ \Delta G^\circ Δ G ∘ ). They accelerate the forward rate ( k 1 k_1 k 1 ) and reverse rate ( k − 1 k_{-1} k − 1 ) by the exact same factor: K eq = k 1 k − 1 = constant K_{\text{eq}} = \frac{k_1}{k_{-1}} = \text{constant} K eq = k − 1 k 1 = constant .
Transition State Complementarity: In 1946, Linus Pauling postulated that an enzyme's active site is not complementary to the ground-state substrate (the historic Fischer "lock-and-key" model), but rather is stereochemically and electronically complementary to the transition state ( S ‡ S^\ddagger S ‡ ) . If an enzyme bound the ground-state substrate too tightly, it would fall into a thermodynamic "trough," increasing the activation barrier. By maximizing non-covalent binding interactions (hydrogen bonds, electrostatic contacts, van der Waals dispersion) exclusively at the transition state, the enzyme releases binding energy ( Δ G B \Delta G_B Δ G B ) that offsets the activation barrier.
Primary Catalytic Mechanisms
Enzymes combine four major catalytic strategies:
General Acid-Base Catalysis: Transfer of protons mediated by ionizable amino acid side chains. Unlike specific acid-base catalysis (which depends solely on hydronium H 3 O + H_3O^+ H 3 O + or hydroxide O H − OH^- O H − from the solvent), general acid-base catalysis uses active-site residues (His imidazole, Asp/Glu carboxylates, Lys amino, Cys thiol) that donate or abstract protons at rates faster than water ionization.
Covalent Catalysis: Formation of a transient, high-energy covalent linkage between a nucleophilic residue on the enzyme and an electrophilic center on the substrate (e.g., acyl-enzyme intermediates in chymotrypsin; Schiff base imine intermediates in aldolases).
Metal Ion Catalysis: Bound cofactors ( Z n 2 + , M g 2 + , F e 2 + , M n 2 + Zn^{2+}, Mg^{2+}, Fe^{2+}, Mn^{2+} Z n 2 + , M g 2 + , F e 2 + , M n 2 + ) stabilize developing negative charges on transition states, mediate oxidation-reduction electron transfers, or polarize coordinated water molecules to generate potent nucleophiles at neutral pH. For example, Z n 2 + Zn^{2+} Z n 2 + in carbonic anhydrase lowers the p K a pK_a p K a of water from 15.7 15.7 15.7 to 7.0 7.0 7.0 , producing an active nucleophilic hydroxide ( O H − OH^- O H − ) that attacks C O 2 CO_2 C O 2 to form H C O 3 − HCO_3^- H C O 3 − at turnover rates exceeding 10 6 s − 1 10^6\text{ s}^{-1} 1 0 6 s − 1 .
Proximity and Orientation Effects: The active site freezes out the translational and rotational degrees of freedom of substrates, aligning reactive orbitals in optimal geometries with negligible conformational entropy loss in the transition state.
The Serine Protease Mechanism: Catalytic Triad and Oxyanion Hole
Chymotrypsin, trypsin, and elastase are classic endopeptidases that hydrolyze interior peptide bonds via a nucleophilic serine mechanism. Architecture of the Chymotrypsin Catalytic Triad:
- Asp 102 His 57 Ser 195
- O H H
- | | |
- -C--O^- ······· N-δ--Imidazole--N-ε: ···· O--CH2--
- | |
- (Carboxylate) (General Base/Acid) (Nucleophile)
- [ Polarizes His ] [ Proton Shuttle ] [ Attacks Carbonyl ]
- The Catalytic Triad
The active site features three invariant residues linked by a precise hydrogen-bonding network:
Aspartate 102: Buried in a low-dielectric hydrophobic pocket; its carboxylate group forms a hydrogen bond with His57, immobilizing it and polarizing its imidazole ring to increase its basicity.
Histidine 57: Acts sequentially as a general base (abstracting a proton from Ser195) and as a general acid (donating a proton to the leaving group).
Serine 195: The primary nucleophile. Deprotonation converts its primary alcohol into an exceptionally reactive, alkoxide-like nucleophile ( − CH 2 − O − -\text{CH}_2-\text{O}^- − CH 2 − O − ).
The Step-by-Step Catalytic Cycle
Substrate Binding: The polypeptide substrate docks into the active site. In chymotrypsin, the bulky aromatic side chain (Phe, Trp, Tyr) slips into a deep, hydrophobic S 1 S_1 S 1 specificity pocket .
Nucleophilic Attack & Tetrahedral Intermediate 1: His57 acts as a general base, abstracting the proton from the Ser195 hydroxyl group. The activated Ser195 oxygen attacks the carbonyl carbon of the scissile peptide bond. The planar s p 2 sp^2 s p 2 carbonyl carbon rehybridizes into a tetrahedral s p 3 sp^3 s p 3 intermediate carrying a negative charge on the carbonyl oxygen ( oxyanion ).
Transition State Stabilization in the Oxyanion Hole: The developing negative charge on the tetrahedral oxygen is stabilized by hydrogen bonds donated from the backbone amide N − H N-H N − H groups of Glycine 193 and Serine 195 . These hydrogen bonds form only in the tetrahedral transition state, not in the planar ground state, accelerating catalysis by a factor of > 10 4 >10^4 > 1 0 4 .
Acyl-Enzyme Formation (Collapse of Intermediate 1): His57 acts as a general acid, donating a proton to the nitrogen atom of the scissile peptide bond. The tetrahedral intermediate collapses, cleaving the peptide linkage: the newly liberated C-terminal peptide fragment departs, leaving the N-terminal portion covalently bonded to Ser195 as an acyl-enzyme intermediate .
Deacylation by Water: A water molecule enters the vacated active site. His57 acts as a general base, abstracting a proton from water. The resulting hydroxide ion ( O H − OH^- O H − ) attacks the carbonyl carbon of the acyl-enzyme intermediate.
Tetrahedral Intermediate 2: Rehybridization generates a second tetrahedral s p 3 sp^3 s p 3 intermediate, again electrostatically stabilized by the oxyanion hole .
Product Release and Triad Regeneration: His57 acts as a general acid, donating its proton back to the oxygen of Ser195. The ester bond collapses, releasing the N-terminal peptide fragment with a newly created free carboxylate group. The catalytic triad returns to its ground state, ready for another cycle.
Michaelis-Menten Kinetics: Steady-State Model and Parameters
In 1913, Leonor Michaelis and Maud Menten proposed a kinetic model based on rapid reversible substrate binding followed by a slow catalytic conversion step. In 1925, G. E. Briggs and J. B. S. Haldane generalized this treatment using the steady-state approximation . Reaction Scheme:
- k1 k2
- E + S <===> ES --------> E + P
- k-1 (kcat)
- The Briggs-Haldane Steady-State Derivation
Let [ E ] t [E]_t [ E ] t represent total enzyme concentration, [ E ] [E] [ E ] free enzyme, [ S ] [S] [ S ] free substrate concentration, and [ E S ] [ES] [ ES ] the enzyme-substrate complex: [ E ] = [ E ] t − [ E S ] [E] = [E]_t - [ES] [ E ] = [ E ] t − [ ES ] .
The Steady-State Assumption: Shortly after mixing, the concentration of the intermediate [ E S ] [ES] [ ES ] reaches a dynamic steady state where its rate of formation equals its rate of breakdown:
d [ E S ] d t = 0 \frac{d[ES]}{dt} = 0 d t d [ ES ] = 0 Rate of [ E S ] formation = k 1 [ E ] [ S ] = k 1 ( [ E ] t − [ E S ] ) [ S ] \text{Rate of } [ES] \text{ formation} = k_1 [E][S] = k_1 ([E]_t - [ES])[S] Rate of [ ES ] formation = k 1 [ E ] [ S ] = k 1 ([ E ] t − [ ES ]) [ S ] Rate of [ E S ] breakdown = ( k − 1 + k 2 ) [ E S ] \text{Rate of } [ES] \text{ breakdown} = (k_{-1} + k_2)[ES] Rate of [ ES ] breakdown = ( k − 1 + k 2 ) [ ES ]
Equating formation and breakdown:
k 1 ( [ E ] t − [ E S ] ) [ S ] = ( k − 1 + k 2 ) [ E S ] k_1 ([E]_t - [ES])[S] = (k_{-1} + k_2)[ES] k 1 ([ E ] t − [ ES ]) [ S ] = ( k − 1 + k 2 ) [ ES ] k 1 [ E ] t [ S ] − k 1 [ E S ] [ S ] = ( k − 1 + k 2 ) [ E S ] k_1 [E]_t [S] - k_1 [ES][S] = (k_{-1} + k_2)[ES] k 1 [ E ] t [ S ] − k 1 [ ES ] [ S ] = ( k − 1 + k 2 ) [ ES ] k 1 [ E ] t [ S ] = ( k − 1 + k 2 + k 1 [ S ] ) [ E S ] k_1 [E]_t [S] = (k_{-1} + k_2 + k_1 [S])[ES] k 1 [ E ] t [ S ] = ( k − 1 + k 2 + k 1 [ S ]) [ ES ] [ E S ] = k 1 [ E ] t [ S ] ( k − 1 + k 2 ) + k 1 [ S ] = [ E ] t [ S ] ( k − 1 + k 2 k 1 ) + [ S ] [ES] = \frac{k_1 [E]_t [S]}{(k_{-1} + k_2) + k_1 [S]} = \frac{[E]_t [S]}{\left(\frac{k_{-1} + k_2}{k_1}\right) + [S]} [ ES ] = ( k − 1 + k 2 ) + k 1 [ S ] k 1 [ E ] t [ S ] = ( k 1 k − 1 + k 2 ) + [ S ] [ E ] t [ S ]
Defining the Michaelis Constant ( K m K_m K m ) :
K m = k − 1 + k 2 k 1 K_m = \frac{k_{-1} + k_2}{k_1} K m = k 1 k − 1 + k 2
Initial velocity is governed by product formation ( v 0 = k 2 [ E S ] v_0 = k_2 [ES] v 0 = k 2 [ ES ] ), and maximal velocity occurs when the enzyme is completely saturated ( V max = k 2 [ E ] t V_{\text{max}} = k_2 [E]_t V max = k 2 [ E ] t ):
v 0 = k 2 [ E ] t [ S ] K m + [ S ] = V max [ S ] K m + [ S ] v_0 = \frac{k_2 [E]_t [S]}{K_m + [S]} = \frac{V_{\text{max}}[S]}{K_m + [S]} v 0 = K m + [ S ] k 2 [ E ] t [ S ] = K m + [ S ] V max [ S ] Hyperbolic Michaelis-Menten Velocity Profile:
- Velocity ^
- v0 |
- Vmax ---+-----------------------------------
| ..................
1/2 Vmax - - - - - - - - - - -/
| . :
| . :
| . :
| . :
- +------+-------------+--------------> [S] Substrate Concentration
- 0 Km
- Kinetic Constants and Their Diagnostic Meanings
Constant Symbol & Units Mathematical Definition Physical & Biochemical Significance
Michaelis Constant K m K_m K m ( M \text{M} M , mM \text{mM} mM , μ M \mu\text{M} μ M ) [ S ] [S] [ S ] at v 0 = 1 2 V max v_0 = \frac{1}{2}V_{\text{max}} v 0 = 2 1 V max Operational measure of substrate affinity. When k 2 ≪ k − 1 k_2 \ll k_{-1} k 2 ≪ k − 1 , K m ≈ K d = k − 1 k 1 K_m \approx K_d = \frac{k_{-1}}{k_1} K m ≈ K d = k 1 k − 1 . Smaller K m K_m K m reflects tighter binding/higher affinity ; independent of [ E ] t [E]_t [ E ] t .
Maximal Velocity V max V_{\text{max}} V max ( μ mol ⋅ L − 1 ⋅ s − 1 \mu\text{mol}\cdot\text{L}^{-1}\cdot\text{s}^{-1} μ mol ⋅ L − 1 ⋅ s − 1 ) k cat [ E ] t k_{\text{cat}} [E]_t k cat [ E ] t Asymptotic velocity at infinite substrate concentration ( [ S ] ≫ K m [S] \gg K_m [ S ] ≫ K m ) where all active sites are saturated; directly proportional to [ E ] t [E]_t [ E ] t .
Turnover Number k cat k_{\text{cat}} k cat ( s − 1 \text{s}^{-1} s − 1 ) V max [ E ] t \frac{V_{\text{max}}}{[E]_t} [ E ] t V max First-order rate constant of the catalytic step; number of substrate molecules converted to product per active site per unit time. Inverse ( 1 / k cat 1/k_{\text{cat}} 1/ k cat ) is time per catalytic event.
Catalytic Efficiency k cat K m \frac{k_{\text{cat}}}{K_m} K m k cat ( M − 1 s − 1 \text{M}^{-1}\text{s}^{-1} M − 1 s − 1 ) Apparent 2nd-order rate constant Evaluates enzyme performance when [ S ] ≪ K m [S] \ll K_m [ S ] ≪ K m . Upper limit set by diffusion ( 10 8 − 10 9 M − 1 s − 1 \mathbf{10^8 - 10^9\text{ M}^{-1}\text{s}^{-1}} 1 0 8 − 1 0 9 M − 1 s − 1 ), termed catalytic perfection (e.g., acetylcholinesterase, carbonic anhydrase).
Limiting Kinetic Regimes
Low Substrate ( [ S ] ≪ K m [S] \ll K_m [ S ] ≪ K m ): The denominator K m + [ S ] ≈ K m K_m + [S] \approx K_m K m + [ S ] ≈ K m . The rate law simplifies to v 0 = ( V max K m ) [ S ] = ( k cat K m ) [ E ] t [ S ] v_0 = \left(\frac{V_{\text{max}}}{K_m}\right)[S] = \left(\frac{k_{\text{cat}}}{K_m}\right)[E]_t [S] v 0 = ( K m V max ) [ S ] = ( K m k cat ) [ E ] t [ S ] . Kinetics are first-order with respect to substrate.
Saturating Substrate ( [ S ] ≫ K m [S] \gg K_m [ S ] ≫ K m ): The denominator K m + [ S ] ≈ [ S ] K_m + [S] \approx [S] K m + [ S ] ≈ [ S ] . The rate law simplifies to v 0 = V max [ S ] [ S ] = V max v_0 = \frac{V_{\text{max}}[S]}{[S]} = V_{\text{max}} v 0 = [ S ] V max [ S ] = V max . Kinetics are zero-order with respect to substrate; rate is independent of [ S ] [S] [ S ] .
Worked Quantitative Kinetics Problem
Problem: An enzyme-catalyzed reaction with [ E ] t = 2.0 nM [E]_t = 2.0\text{ nM} [ E ] t = 2.0 nM ( 2.0 × 10 − 9 M 2.0 \times 10^{-9}\text{ M} 2.0 × 1 0 − 9 M ) exhibits V max = 1.2 μ M ⋅ s − 1 V_{\text{max}} = 1.2\text{ }\mu\text{M}\cdot\text{s}^{-1} V max = 1.2 μ M ⋅ s − 1 ( 1.2 × 10 − 6 M ⋅ s − 1 1.2 \times 10^{-6}\text{ M}\cdot\text{s}^{-1} 1.2 × 1 0 − 6 M ⋅ s − 1 ) and K m = 40 μ M K_m = 40\text{ }\mu\text{M} K m = 40 μ M ( 4.0 × 10 − 5 M 4.0 \times 10^{-5}\text{ M} 4.0 × 1 0 − 5 M ).
Calculate the turnover number ( k cat k_{\text{cat}} k cat ): k cat = V max [ E ] t = 1.2 × 10 − 6 M ⋅ s − 1 2.0 × 10 − 9 M = 600 s − 1 k_{\text{cat}} = \frac{V_{\text{max}}}{[E]_t} = \frac{1.2 \times 10^{-6}\text{ M}\cdot\text{s}^{-1}}{2.0 \times 10^{-9}\text{ M}} = 600\text{ s}^{-1} k cat = [ E ] t V max = 2.0 × 1 0 − 9 M 1.2 × 1 0 − 6 M ⋅ s − 1 = 600 s − 1
Calculate the catalytic efficiency ( k cat / K m k_{\text{cat}}/K_m k cat / K m ): k cat K m = 600 s − 1 4.0 × 10 − 5 M = 1.5 × 10 7 M − 1 s − 1 \frac{k_{\text{cat}}}{K_m} = \frac{600\text{ s}^{-1}}{4.0 \times 10^{-5}\text{ M}} = 1.5 \times 10^7\text{ M}^{-1}\text{s}^{-1} K m k cat = 4.0 × 1 0 − 5 M 600 s − 1 = 1.5 × 1 0 7 M − 1 s − 1 (This enzyme approaches the diffusion-controlled limit of 10 8 − 10 9 M − 1 s − 1 10^8-10^9\text{ M}^{-1}\text{s}^{-1} 1 0 8 − 1 0 9 M − 1 s − 1 ).
Determine initial velocity when [ S ] = 10 μ M [S] = 10\text{ }\mu\text{M} [ S ] = 10 μ M : v 0 = V max [ S ] K m + [ S ] = ( 1.2 μ M ⋅ s − 1 ) ( 10 μ M ) 40 μ M + 10 μ M = 12 50 = 0.24 μ M ⋅ s − 1 v_0 = \frac{V_{\text{max}}[S]}{K_m + [S]} = \frac{(1.2\text{ }\mu\text{M}\cdot\text{s}^{-1})(10\text{ }\mu\text{M})}{40\text{ }\mu\text{M} + 10\text{ }\mu\text{M}} = \frac{12}{50} = 0.24\text{ }\mu\text{M}\cdot\text{s}^{-1} v 0 = K m + [ S ] V max [ S ] = 40 μ M + 10 μ M ( 1.2 μ M ⋅ s − 1 ) ( 10 μ M ) = 50 12 = 0.24 μ M ⋅ s − 1
Graphical Linearization: Lineweaver-Burk and Alternative Plots
Because non-linear hyperbolic curves make accurate visual determination of V max V_{\text{max}} V max and K m K_m K m difficult, kinetic data are linearized: Lineweaver-Burk Double-Reciprocal Plot:
- 1/v0 ^
- | / (Slope = Km / Vmax)
- | /
- | /
- 1/Vmax +--------+ (y-intercept = 1 / Vmax)
- | /
- | /
- | /
- ------+----+-------------------------> 1/[S]
- 1/Km | 0
- (x-intercept = -1/Km)
- Mathematical Formulation of Linear Plots
Lineweaver-Burk (Double-Reciprocal) Plot: Taking the reciprocal of both sides of the Michaelis-Menten equation:
1 v 0 = K m + [ S ] V max [ S ] = ( K m V max ) 1 [ S ] + 1 V max \frac{1}{v_0} = \frac{K_m + [S]}{V_{\text{max}}[S]} = \left(\frac{K_m}{V_{\text{max}}}\right)\frac{1}{[S]} + \frac{1}{V_{\text{max}}} v 0 1 = V max [ S ] K m + [ S ] = ( V max K m ) [ S ] 1 + V max 1
- y y y -variable: 1 v 0 \frac{1}{v_0} v 0 1
- x x x -variable: 1 [ S ] \frac{1}{[S]} [ S ] 1
- Slope: K m V max \frac{K_m}{V_{\text{max}}} V max K m
y y y -intercept: 1 V max \frac{1}{V_{\text{max}}} V max 1 (set 1 [ S ] = 0 \frac{1}{[S]} = 0 [ S ] 1 = 0 )
x x x -intercept: − 1 K m -\frac{1}{K_m} − K m 1 (set 1 v 0 = 0 \frac{1}{v_0} = 0 v 0 1 = 0 )
Eadie-Hofstee Plot: v 0 = − K m ( v 0 [ S ] ) + V max v_0 = -K_m \left(\frac{v_0}{[S]}\right) + V_{\text{max}} v 0 = − K m ( [ S ] v 0 ) + V max . Plotting v 0 v_0 v 0 vs. v 0 / [ S ] v_0/[S] v 0 / [ S ] yields slope = − K m = -K_m = − K m , y y y -intercept = V max = V_{\text{max}} = V max , and x x x -intercept = V max / K m = V_{\text{max}}/K_m = V max / K m . Does not disproportionately weight data at low [ S ] [S] [ S ] .
Hanes-Woolf Plot: [ S ] v 0 = ( 1 V max ) [ S ] + K m V max \frac{[S]}{v_0} = \left(\frac{1}{V_{\text{max}}}\right)[S] + \frac{K_m}{V_{\text{max}}} v 0 [ S ] = ( V max 1 ) [ S ] + V max K m . Plotting [ S ] / v 0 [S]/v_0 [ S ] / v 0 vs. [ S ] [S] [ S ] yields slope = 1 V max = \frac{1}{V_{\text{max}}} = V max 1 , y y y -intercept = K m V max = \frac{K_m}{V_{\text{max}}} = V max K m , and x x x -intercept = − K m = -K_m = − K m .
Reversible Enzyme Inhibition
Reversible inhibitors bind non-covalently to enzymes, establishing rapid thermodynamic equilibria. They are categorized based on whether they bind to free enzyme ( E E E ), the enzyme-substrate complex ( E S ES ES ), or both:
α = 1 + [ I ] K I and α ′ = 1 + [ I ] K I ′ \alpha = 1 + \frac{[I]}{K_I} \quad \text{and} \quad \alpha' = 1 + \frac{[I]}{K_I'} α = 1 + K I [ I ] and α ′ = 1 + K I ′ [ I ]
Where K I = [ E ] [ I ] [ E I ] K_I = \frac{[E][I]}{[EI]} K I = [ E I ] [ E ] [ I ] and K I ′ = [ E S ] [ I ] [ E S I ] K_I' = \frac{[ES][I]}{[ESI]} K I ′ = [ ES I ] [ ES ] [ I ] .
Inhibition Type Target Binding Species Apparent V max V_{\text{max}} V max ( V max app V_{\text{max}}^{\text{app}} V max app ) Apparent K m K_m K m ( K m app K_m^{\text{app}} K m app ) Lineweaver-Burk Intersection Diagnostic Physical Behavior
Competitive Free Enzyme ( E E E ) only Unchanged ( V max V_{\text{max}} V max ) Increased ( α K m \alpha K_m α K m ) On y y y -axis ( 1 / V max 1/V_{\text{max}} 1/ V max ) Overcome by high [ S ] [S] [ S ] ; inhibitor mimics substrate structure; statins (atorvastatin) inhibiting HMG-CoA reductase
Uncompetitive E S ES ES complex only Decreased ( V max / α ′ V_{\text{max}}/\alpha' V max / α ′ ) Decreased ( K m / α ′ K_m/\alpha' K m / α ′ ) Parallel lines (identical slope) Cannot be overcome by [ S ] [S] [ S ] ; inhibitor binds to pocket formed upon substrate binding; lithium inhibiting inositol monophosphatase
Pure Non-competitive E E E and E S ES ES equally ( K I = K I ′ K_I = K_I' K I = K I ′ ) Decreased ( V max / α V_{\text{max}}/\alpha V max / α ) Unchanged ( K m K_m K m ) On negative x x x -axis ( − 1 / K m -1/K_m − 1/ K m ) Inhibitor binds allosteric site; reduces active enzyme concentration without altering affinity
Mixed E E E and E S ES ES unequally ( K I ≠ K I ′ K_I \neq K_I' K I = K I ′ ) Decreased ( V max / α ′ V_{\text{max}}/\alpha' V max / α ′ ) Altered ( K m ⋅ α α ′ K_m \cdot \frac{\alpha}{\alpha'} K m ⋅ α ′ α ) Left of y y y -axis (above or below x x x -axis) If K I < K I ′ K_I < K_I' K I < K I ′ : prefers E E E , K m K_m K m increases; if K I > K I ′ K_I > K_I' K I > K I ′ : prefers E S ES ES , K m K_m K m decreases Double-Reciprocal Profiles of Reversible Inhibition:
- Competitive: (Cross at y-axis) Uncompetitive: (Parallel lines) Non-competitive: (Cross at x-axis)
- 1/v0 ^ + Inhibitor 1/v0 ^ + Inhibitor 1/v0 ^ + Inhibitor
- | / | / | /
- | / | / | /
- 1/Vmax +----+ Control 1/Vmax +----+ Control 1/Vmax +----+ Control
- | / | / | /
- --------+--+----------> 1/[S] ----------+--+----------> 1/[S] ----------+--+----------> 1/[S]
- | 0 | 0 -1/Km 0
- Irreversible Inhibition and Suicide Inactivators
Irreversible inhibitors (inactivators) chemically destroy or covalently modify functional catalytic groups in the active site, resulting in permanent loss of enzymatic activity. They cannot be dissociated by dilution or prolonged dialysis.
Classic Irreversible Inhibitor Systems
Organophosphates (DFP and Nerve Agents): Diisopropyl fluorophosphate ( DFP ), Sarin, and agricultural organophosphate insecticides (Malathion, Parathion) contain a labile phosphoryl-fluoride or phosphorothioate bond. The active-site Ser195 of acetylcholinesterase (AChE) attacks the phosphorus atom, releasing fluoride and forming an extremely stable, covalent diisopropylphosphoryl-serine ester . This blocks the breakdown of acetylcholine at neuromuscular junctions, causing continuous cholinergic stimulation, muscle fasciculations, respiratory arrest, and death.
Antidote Mechanism: Pralidoxime (2-PAM) is a strong nucleophile with a quaternary pyridinium nitrogen that docks near the AChE anionic subsite. Its oxime group ( − CH = N − OH -\text{CH}=\text{N}-\text{OH} − CH = N − OH ) attacks the phosphorus atom, cleaving the covalent organophosphate bond and regenerating active AChE, provided administration occurs before aging (dealkylation of the organophosphate).
Penicillin and β \beta β -Lactam Antibiotics (Suicide Inhibition): Bacterial transpeptidase (penicillin-binding protein) cross-links peptide chains during peptidoglycan cell-wall synthesis by recognizing a terminal − D − Ala − D − Ala -\text{D}-\text{Ala}-\text{D}-\text{Ala} − D − Ala − D − Ala dipeptide. Penicillin acts as a suicide (mechanism-based) inhibitor : its strained four-membered β \beta β -lactam ring mimics the transition state of − D − Ala − D − Ala -\text{D}-\text{Ala}-\text{D}-\text{Ala} − D − Ala − D − Ala . The catalytic Ser hydroxyl attacks the β \beta β -lactam carbonyl, opening the ring to form a stable penicilloyl-enzyme conjugate that cannot be hydrolyzed, arresting bacterial cell-wall construction and inducing osmotic lysis.
Aspirin (Acetylsalicylic Acid): Irreversibly inactivates cyclooxygenase-1 (COX-1) by covalently transferring its acetyl group to Serine 530 , located near the catalytic pocket. Acetylation sterically blocks the entry of arachidonic acid, shutting down thromboxane A 2 A_2 A 2 synthesis in platelets for their entire 10-day lifespan.
Allosteric Enzymes and Cooperative Kinetics
Not all enzymes follow hyperbolic Michaelis-Menten kinetics. Allosteric enzymes are oligomers with multiple active sites that display sigmoidal (S-shaped) velocity curves ( v 0 v_0 v 0 vs. [ S ] [S] [ S ] ). Allosteric Sigmoidal Curve and Effector Modulations:
- Velocity ^
- v0 | + Positive Allosteric Effector (Activator, shifts curve LEFT to R-state)
- | .--'
- Vmax | .-' -- Base Sigmoidal Curve (Cooperative, Hill nH > 1)
- | .' .-
- | / .' + Negative Allosteric Effector (Inhibitor, shifts curve RIGHT to T-state)
- | / .' .'
- | / .' .-'
- +---+--+----+------------------------> [S]
- 0 K0.5
- Theoretical Models: MWC vs. KNF
Monod-Wyman-Changeux (MWC) Concerted Model: The enzyme exists in an equilibrium between two distinct conformational states: the T-state (Tense) , which has low substrate affinity, and the R-state (Relaxed) , which has high substrate affinity. All subunits change conformation simultaneously in a concerted "all-or-none" transition. Substrate binding shifts the equilibrium toward the R-state.
Koshland-Némethy-Filmer (KNF) Sequential Model: Substrate binding to one subunit induces a local conformational change that alters the binding affinity of adjacent subunits sequentially via an induced-fit mechanism.
The Hill Equation and Coefficient ( n H n_H n H )
Cooperativity is quantified using the Hill Equation :
log ( θ 1 − θ ) = n H log [ S ] − log K 0.5 \log\left(\frac{\theta}{1 - \theta}\right) = n_H \log[S] - \log K_{0.5} lo g ( 1 − θ θ ) = n H lo g [ S ] − lo g K 0.5
Where θ = v 0 / V max \theta = v_0 / V_{\text{max}} θ = v 0 / V max is fractional active site saturation, and n H n_H n H is the Hill coefficient :
n H = 1 n_H = 1 n H = 1 : Non-cooperative binding; hyperbolic Michaelis-Menten kinetics.
n H > 1 n_H > 1 n H > 1 : Positive cooperativity ; binding of substrate to one subunit enhances affinity of remaining subunits (e.g., hemoglobin, n H ≈ 2.8 − 3.0 n_H \approx 2.8-3.0 n H ≈ 2.8 − 3.0 ; ATCase, n H ≈ 2.5 n_H \approx 2.5 n H ≈ 2.5 ).
n H < 1 n_H < 1 n H < 1 : Negative cooperativity ; binding of substrate decreases affinity of remaining subunits.
Allosteric Systems: K K K -Systems vs. V V V -Systems
K K K -Systems: Allosteric effectors alter the apparent affinity constant ( K 0.5 K_{0.5} K 0.5 or [ S ] 0.5 [S]_{0.5} [ S ] 0.5 ) without changing V max V_{\text{max}} V max . Activators shift the sigmoidal curve to the left (decreasing K 0.5 K_{0.5} K 0.5 ); inhibitors shift it to the right (increasing K 0.5 K_{0.5} K 0.5 ). Case Study: Aspartate Transcarbamoylase (ATCase) catalyzes the first committed step of pyrimidine biosynthesis ( c a r b a m o y l phosphate + L − a s p a r t a t e → N − c a r b a m o y l a s p a r t a t e carbamoyl \text{ phosphate} + L-aspartate \rightarrow N-carbamoylaspartate c a r bam oy l phosphate + L − a s p a r t a t e → N − c a r bam oy l a s p a r t a t e ). It is allosterically activated by ATP (a purine, signaling energy abundance and nucleotide balance) and feedback-inhibited by CTP (a pyrimidine end-product).
V V V -Systems: Allosteric effectors alter V max V_{\text{max}} V max without modifying K 0.5 K_{0.5} K 0.5 .